SCHEMBL7420199

SCHEMBL7420199

CCCc1c(C(=O)CC(C)OC)c2ccc(C(N)=O)cc2n1Cc1cc2c(cc1Cl)OCO2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 1/20 0.37
CHEK2 O96017 1/20 0.35
EDNRA P25101 9/20 0.35
EDNRB P24530 7/20 0.35
PPARG P37231 1/20 0.33
PLA2G2A P14555 1/20 0.32
PDE4A P27815 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
OXER1 Q8TDS5 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C19 P33261 1/20 0.31
KCNH2 Q12809 1/20 0.31
MCHR1 Q99705 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7426123 0.89 SLC22A12 (0.39) SLC22A12CHEK2EDNRAEDNRBPLA2G2A
SCHEMBL7420485 0.86 ALOX5AP (0.42) PLA2G2AOXER1MEN1KMT2ACYP1A2
SCHEMBL7426853 0.86 SLC22A12 (0.40) SLC22A12CHEK2EDNRAEDNRBPDE4A
SCHEMBL7418953 0.83 EDNRA (0.39) SLC22A12CHEK2EDNRAEDNRBPDE4A
SCHEMBL7427382 0.82 SLC22A12 (0.39) SLC22A12CHEK2EDNRAEDNRBPDE4A
SCHEMBL7420854 0.81 EDNRA (0.38) SLC22A12CHEK2EDNRAEDNRBMEN1
SCHEMBL7426188 0.81 EDNRA (0.38) SLC22A12CHEK2EDNRAEDNRBMEN1
SCHEMBL7422738 0.81 EDNRA (0.38) SLC22A12CHEK2EDNRAEDNRBMEN1
SCHEMBL7422706 0.81 SLC22A12 (0.41) SLC22A12EDNRAEDNRB
SCHEMBL7427422 0.81 NPC1 (0.37) SLC22A12CHEK2EDNRAEDNRBPLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed